Business Description
MedAvail Holdings Inc
NAICS : 446110
SIC : 5912
ISIN : US58406B2025
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.34 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 5/9 | |||||
Beneish M-Score | -4.01 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 76.5 | |||||
3-Year EBITDA Growth Rate | -1.6 | |||||
3-Year EPS without NRI Growth Rate | -2.1 | |||||
3-Year FCF Growth Rate | -6.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.25 | |||||
9-Day RSI | 4.47 | |||||
14-Day RSI | 14.48 | |||||
6-1 Month Momentum % | -67.38 | |||||
12-1 Month Momentum % | -87.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.51 | |||||
Quick Ratio | 4.09 | |||||
Cash Ratio | 3.46 | |||||
Days Inventory | 123.85 | |||||
Days Sales Outstanding | 21.58 | |||||
Days Payable | 27.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 6.72 | |||||
Operating Margin % | -132.99 | |||||
Net Margin % | -192.97 | |||||
FCF Margin % | -135.22 | |||||
ROE % | -205.1 | |||||
ROA % | -114.17 | |||||
ROIC % | -206.74 | |||||
ROC (Joel Greenblatt) % | -313.62 | |||||
ROCE % | -117.08 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | 0.3 | |||||
EV-to-EBITDA | 0.34 | |||||
EV-to-Revenue | -0.51 | |||||
EV-to-FCF | 0.38 | |||||
Earnings Yield (Greenblatt) % | 333.33 | |||||
FCF Yield % | -7.17 |